CN105963527A - 伤口快速愈合中药提取液及其制备方法 - Google Patents
伤口快速愈合中药提取液及其制备方法 Download PDFInfo
- Publication number
- CN105963527A CN105963527A CN201610405399.0A CN201610405399A CN105963527A CN 105963527 A CN105963527 A CN 105963527A CN 201610405399 A CN201610405399 A CN 201610405399A CN 105963527 A CN105963527 A CN 105963527A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- rhizoma
- wound healing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 102
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 208000027418 Wounds and injury Diseases 0.000 title abstract description 22
- 206010052428 Wound Diseases 0.000 title abstract description 18
- 230000035876 healing Effects 0.000 title abstract description 5
- 230000029663 wound healing Effects 0.000 claims abstract description 29
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 12
- 239000004863 Frankincense Substances 0.000 claims abstract description 11
- 239000007788 liquid Substances 0.000 claims description 38
- 238000000605 extraction Methods 0.000 claims description 22
- 238000000855 fermentation Methods 0.000 claims description 22
- 230000004151 fermentation Effects 0.000 claims description 22
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000009286 sanguis draxonis Substances 0.000 claims description 14
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 13
- 241001057584 Myrrha Species 0.000 claims description 11
- 241000717739 Boswellia sacra Species 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 241001468229 Bifidobacterium thermophilum Species 0.000 claims description 4
- 241000186012 Bifidobacterium breve Species 0.000 claims description 3
- 241001608472 Bifidobacterium longum Species 0.000 claims description 3
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 3
- 239000006041 probiotic Substances 0.000 claims description 2
- 235000018291 probiotics Nutrition 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 230000008901 benefit Effects 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 210000002950 fibroblast Anatomy 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000000857 drug effect Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 102000013275 Somatomedins Human genes 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229940126678 chinese medicines Drugs 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000003387 muscular Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- 206010002515 Animal bite Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000013883 Blast injury Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000018380 Chemical injury Diseases 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 208000019155 Radiation injury Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000009707 neogenesis Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及伤口快速愈合药物,尤其涉及一种伤口快速愈合中药提取液及其制备方法。包括以下有效组份:当归、地榆、紫草、大黄、黄连、黄柏、虎杖、乳香、刘寄奴、白及、白芷、没药、苦楝皮、冰片、龙血竭。与现有技术相比,本发明的优点和积极效果在于,本发明通过提供一种中药提取液,利用科学的配伍,使各中药之间相互协同,发挥最大药效,同时,利用独特的制备方法,有效的将中药的成分进行提取,充分发挥中药的药效,且,采用提取液的方式,也能够有效的去除中药微毒性和小副作用,进而达到快速治愈伤口的目的。
Description
技术领域
本发明涉及伤口快速愈合药物,尤其涉及一种伤口快速愈合中药提取液及其制备方法。
背景技术
在人类的日常生活中,人类经常因为无意或其他状况导致出现外伤的现象,因此,从古至今,皮肤创伤、损伤都是外科临床常见病,例如烧烫伤、各种外伤、皮肤溃疡、粘膜损伤等等都属于外科伤口,如不及时医治,病邪和细菌侵入,不仅会扩大创面,皮肤溃烂,甚至造成感染,产生败血症,导致死亡。创伤修复始终是外科领域中的研究热点之一。创面愈合是创伤后引起的一个病理过程的,是由多种生长因子、细胞因子、炎症细胞及修复细胞共同参与,复杂而又高度协调的过程。创面愈合过程复杂,影响因素众多,除了成纤维细胞、炎症细胞、生长因子、纤维结合蛋白微量元素、pH值等,还有细胞外基质、表皮细胞及多种细胞因子。
现代医学认为,创面的愈合过程大体上分为局部炎症反应、细胞增殖分化和组织修复重建3个彼此有别又重叠的阶段。这3个阶段任何一个环节受到影响,都可能导致创面愈合时间的延长,因此,有效控制局部感染、促进细胞增殖、增加胶原合成和创面营养,成为加速创面愈合行之有效的方法。
具体的说,皮肤创伤愈合是皮肤组织受到损伤后的修复过程,修复过程包括炎症反应、细胞增生和新生组织重塑等。炎症反应包括各种细胞因子、白细胞等;细胞新生包括纤维母细胞自体增殖或是间充质细胞分化为纤维母细胞等;组织重塑包括纤维母细胞的有序重排成有一定功能的皮肤组织。由此,纤维母细胞是皮肤真皮中的主体细胞成分,它与自身分泌的胶原纤维、弹性纤维及基质成分一同构成了真皮的主体。纤维母细胞的主要功能是:合成和分泌胶原纤维、弹性纤维、基质大分子物质和某些生长因子,对维持皮肤的弹性和 韧性具有重要作用,纤维母细胞的减少也是引起皱纹产生的重要原因。
但常用的外伤药品中存在不足。如消毒剂(碘伏等)、创可贴的使用,可起到杀菌消毒作用,但并不能减少创伤疼痛;外用利多卡因乳膏和气雾剂,可起到止痛作用,但控制感染差;其它以中药提取物为主药,大多为医疗器械类,质量控制标准不严格;外用药品剂型上多为软膏、搽剂,给药存在不便。
发明内容
本发明针对上述的传统的外伤药品中纯存在的不足,提出一种配方合理、制作简便、创伤愈合快、愈合好的伤口快速愈合中药提取液及其制备方法。
为了达到上述目的,本发明采用的技术方案为,本发明提供一种伤口快速愈合中药提取液,其特征在于,包括以下有效组份:当归、地榆、紫草、大黄、黄连、黄柏、虎杖、乳香、刘寄奴、白及、白芷、没药、苦楝皮、冰片、龙血竭。
作为优选,按照重量份数包括以下有效组份:当归5份~10份、地榆10份~20份、紫草5份~10份、大黄5份~10份、黄连7份~15份、黄柏5份~10份、虎杖3份~8份、乳香5份~10份、刘寄奴5份~10份、白及5份~10份、白芷5份~10份、没药7份~15份、苦楝皮5份~10份、冰片2份~8份、龙血竭5份~10份。
更为优选的是,按照重量份数包括以下有效组份:当归10份、地榆20份、紫草10份、大黄10份、黄连8份、黄柏10份、虎杖5份、乳香8份、刘寄奴10份、白及7份、白芷8份、没药7份、苦楝皮5份、冰片6份、龙血竭10份。
本发明还提供了制备上述伤口快速愈合中药提取液的方法,包括以下步骤:
a、将准备好的中药组份在沸水中快速浸泡过滤下,然后迅速捞出,沥干;
b、将沥干后的中药切段成碎末状,然后放入锅内干锅翻炒;
c、将翻炒过后的中药放入锅中,加水,慢火熬制1小时;
d、待锅内药水冷却后,将中药以及药水放入发酵罐内,添加菌种,进行发酵;
e、待发酵完成后,取出发酵好的中药及药水,过滤,得到过滤液;
f、将过滤液进行高温压缩,压缩至相对浓度为1.5~1.7,即得到成品。
作为优选,所述c步骤中,加水量为中药总重量的2~3倍。
作为优选,所述d步骤中,菌种为酵母菌和双歧杆菌的混合物,所述添加菌种的量为中药总重量的1%~4%。
作为优选,所述酵母菌和双歧杆菌的质量比为1:1.5。
作为优选,所述双歧杆菌为长双歧杆菌、短双歧杆菌、卵形双歧杆菌、嗜热双歧杆菌中的至少一种有益菌。
作为优选,所述d步骤中,控制发酵罐内发酵温度24℃~28℃,发酵时间为28~48小时。
与现有技术相比,本发明的优点和积极效果在于,
1、本发明通过提供一种中药提取液,利用科学的配伍,使各中药之间相互协同,发挥最大药效,同时,利用独特的制备方法,有效的将中药的成分进行提取,充分发挥中药的药效,且,采用提取液的方式,也能够有效的去除中药微毒性和小副作用,进而达到快速治愈伤口的目的。
具体实施方式
为了能够更清楚地理解本发明的上述目的、特征和优点,下面结合实施例对本发明做进一步说明。需要说明的是,在不冲突的情况下,本申请的实施例及实施例中的特征可以相互组合。
在下面的描述中阐述了很多具体细节以便于充分理解本发明,但是,本发明还可以采用不同于在此描述的其他方式来实施,因此,本发明并不限于下面公开说明书的具体实施例的限制。
实施例1,本实施例提供一种伤口快速愈合中药提取液,包括以下有效组份:当归5份、地榆10份、紫草5份、大黄5份、黄连7份、黄柏5份、虎杖3份、乳香5份、刘寄奴5份、白及5份、白芷5份、没药7份、苦楝皮5份、冰片2份、龙血竭5份。
在上述配方中,当归具有补血;活血;调经止痛;润燥滑肠的功效,能够 补血、活血,且具有抑菌、抗动脉硬化作用;地榆具有凉血止血,清热解毒,消肿敛疮的功效;紫草,具有凉血,活血,解毒透疹的功效;大黄具有活血祛瘀的功效;黄连具有清热燥湿,泻火解毒,更可以与大黄之间更好的配伍,提高效果;黄柏,具有清热解毒、清热燥湿的功效;虎杖具有清热解毒的功效,且具有治疗水火烫伤,跌扑损伤,痈肿疮毒的作用;乳香具有较显著的镇痛作用,且能够有更强烈的抑菌作用;刘寄奴具有疗伤止血的功效;白及具有收敛止血,消肿生肌的功效;白芷具有活血排脓,生肌止痛的功效;没药具有活血止痛、消肿生肌等功效;苦楝皮具有清热的功效;冰片具有消肿止痛之功效;龙血竭具有活血化瘀、消肿止痛、收敛止血,软坚散结、生肌敛疮等显著功效,通过上述中药成份,以龙血竭、刘寄奴、地榆、大黄为君药,配以紫草、黄连、白芷、没药、当归、白及为臣药,最后配以黄柏、虎杖、乳香、冰片等药物,达到伤口快速愈合的目的,且消除在伤口愈合过程中,产生的一些不适,比如,感染、疼痛等症状。
具体制备时,首先,将准备好的中药组份在沸水中快速浸泡过滤下,然后迅速捞出,沥干,快速的浸泡有利于杀死一些表面的细菌,且不影响中药的药效,待中药沥干后,将中药切段成碎末状,放入锅内干锅翻炒,干锅翻炒的目的在于将当归、龙血竭、黄柏等中药的有效成份在后期的发酵过程中,更好的分解出来,提高中药发酵的效果,翻炒时间以药物具有30~40℃的温度后,停止翻炒,待翻炒过后,将翻炒后中药粉末放入锅中,加水,加水量为中药总重量的2~3倍即可,然后慢火熬制1小时,熬制完成后,待锅内药水冷却后,将中药以及熬制的药水放入发酵罐内,添加菌种,菌种的添加量为中药总重量的1%~4%,在本实施例中,为1%,菌种最好为酵母菌和双歧杆菌的混合物,当然也可以是单一的酵母菌或双歧杆菌,在本实施例中,酵母菌和双歧杆菌的质量比为1:1.5,具体的说,双岐杆菌为长双歧杆菌和短双歧杆菌的混合菌种,然后密封,然后控制发酵罐内温度24℃~28℃,发酵时间为36小时进行发酵;待发酵完成后,取出发酵好的中药及药水,过滤,得到过滤液;然后,将过滤液进行高温压缩,压缩至相对浓度为1.5~1.7,即得到成品。
实施例2,本实施例提供一种伤口快速愈合中药提取液,包括以下有效组份:当归10份、地榆20份、紫草10份、大黄10份、黄连15份、黄柏10份、虎杖8份、乳香10份、刘寄奴10份、白及10份、白芷10份、没药15份、苦楝皮10份、冰片8份、龙血竭10份。
具体制备时,首先,将准备好的中药组份在沸水中快速浸泡过滤下,然后迅速捞出,沥干,快速的浸泡有利于杀死一些表面的细菌,且不影响中药的药效,待中药沥干后,将中药切段成碎末状,放入锅内干锅翻炒,干锅翻炒的目的在于将当归、龙血竭、黄柏等中药的有效成份在后期的发酵过程中,更好的分解出来,提高中药发酵的效果,翻炒时间以药物具有30~40℃的温度后,停止翻炒,待翻炒过后,将翻炒后中药粉末放入锅中,加水,加水量为中药总重量的2~3倍即可,然后慢火熬制1小时,熬制完成后,待锅内药水冷却后,将中药以及熬制的药水放入发酵罐内,添加菌种,菌种的添加量为中药总重量的1%~4%,在本实施例中,为3%,菌种最好为酵母菌和双歧杆菌的混合物,当然也可以是单一的酵母菌或双歧杆菌,在本实施例中,酵母菌和双歧杆菌的质量比为1:1.5,具体的说,双岐杆菌为卵形双歧杆菌和嗜热双歧杆菌的混合菌种,然后密封,然后控制发酵罐内温度24℃~28℃,发酵时间为28小时进行发酵;待发酵完成后,取出发酵好的中药及药水,过滤,得到过滤液;然后,将过滤液进行高温压缩,压缩至相对浓度为1.5~1.7,即得到成品。
实施例3,本实施例提供一种伤口快速愈合中药提取液,包括以下有效组份:当归10份、地榆20份、紫草10份、大黄10份、黄连8份、黄柏10份、虎杖5份、乳香8份、刘寄奴10份、白及7份、白芷8份、没药7份、苦楝皮5份、冰片6份、龙血竭10份。
具体制备时,首先,将准备好的中药组份在沸水中快速浸泡过滤下,然后迅速捞出,沥干,快速的浸泡有利于杀死一些表面的细菌,且不影响中药的药效,待中药沥干后,将中药切段成碎末状,放入锅内干锅翻炒,干锅翻炒的目的在于将当归、龙血竭、黄柏等中药的有效成份在后期的发酵过程中,更好的分解出来,提高中药发酵的效果,翻炒时间以药物具有30~40℃的温度后,停 止翻炒,待翻炒过后,将翻炒后中药粉末放入锅中,加水,加水量为中药总重量的2~3倍即可,然后慢火熬制1小时,熬制完成后,待锅内药水冷却后,将中药以及熬制的药水放入发酵罐内,添加菌种,菌种的添加量为中药总重量的1%~4%,在本实施例中,为4%,菌种最好为酵母菌和双歧杆菌的混合物,当然也可以是单一的酵母菌或双歧杆菌,在本实施例中,酵母菌和双歧杆菌的质量比为1:1.5,具体的说,双岐杆菌为卵形双歧杆菌和嗜热双歧杆菌的混合菌种,然后密封,然后控制发酵罐内温度24℃~28℃,发酵时间为48小时进行发酵;待发酵完成后,取出发酵好的中药及药水,过滤,得到过滤液;然后,将过滤液进行高温压缩,压缩至相对浓度为1.5~1.7,即得到成品。
毒性实验
取ICR小鼠,实验前禁食不禁水15h,均分为19组(每个实施例的试验药物组6组,对照组1组)。各组小鼠尾静脉给药,试验1组至试验6组给药剂量均按剂量分别为500mg/kg、1000mg/kg、2000mg/kg、5000mg/kg、10000mg/kg、20000mg/kg,对照组小鼠给予同体积蒸馏水。仔细观察并记录给药即刻至7d内小鼠出现的毒性反应与死亡情况;采用Bliss’s法计算LD50。实验结果如下表格:
组别 | mg/Kg |
实施例1小组 | 5970.6mg/Kg |
实施例2小组 | 6078.4mg/Kg |
实施例3小组 | 6540.8mg/Kg |
由上表可知药物的LD50都在5970mg/kg以上,显然本药物的毒性很低,在合理的使用范围内,对人体的毒副作用少。
本发明实施例所制备的中药提取液可以用于治疗的外伤包括:人体损伤、人体细T菌感染、皮肤和肌肉组织出血渗血。其中人体损伤包括:擦伤、刃器割伤、刺伤、冲击伤(冲击波作用造成的损伤)、烧伤、冻伤、动物咬伤、化学伤、放射伤以及上述中两种或两种以上组合造成的损伤等;人体细菌感包括:表皮或肌肉组织脓疮、腐烂、溃疡等;皮肤和肌肉组织出血渗血包括: 牙龈出血、鼻出血等。使用方法为:每日服用2~3次,一次100ml即可,也可以涂抹使用。
临床病例:
病例1患者女,61岁,切菜时不慎切伤左手拇指掌侧,直切口,伤及肌肉,当即疼痛,流血,拇指末节不能弯曲,使用本发明提供的的中药提取液,取适量涂抹于创面,包扎,并按剂量服用提取液,三天换一次药,1周后伤口愈合。
病例2患者男,40岁,大腿内侧肌肉感染产生脓疮,后切开引流,引流条内涂抹本发明的提供的的中药提取液,适量,包扎,并按剂量服用提取液,三天换一次药,半月后创面愈合。
病例3患者女,12岁,手部烫伤,使用本发明的中药提取液,取适量涂撒于烫伤创面,一个小时后,疼痛感消除,按剂量服用提取液,并每天2~3次涂抹一次药,4周后创面愈合,没有疤痕。
以上所述,仅是本发明的较佳实施例而已,并非是对本发明作其它形式的限制,任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更或改型为等同变化的等效实施例应用于其它领域,但是凡是未脱离本发明技术方案内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与改型,仍属于本发明技术方案的保护范围。
Claims (9)
1.一种伤口快速愈合中药提取液,其特征在于,包括以下有效组份:当归、地榆、紫草、大黄、黄连、黄柏、虎杖、乳香、刘寄奴、白及、白芷、没药、苦楝皮、冰片、龙血竭。
2.根据权利要求1所述的伤口快速愈合中药提取液,其特征在于,按照重量份数包括以下有效组份:当归5份~10份、地榆10份~20份、紫草5份~10份、大黄5份~10份、黄连7份~15份、黄柏5份~10份、虎杖3份~8份、乳香5份~10份、刘寄奴5份~10份、白及5份~10份、白芷5份~10份、没药7份~15份、苦楝皮5份~10份、冰片2份~8份、龙血竭5份~10份。
3.根据权利要求2所述的伤口快速愈合中药提取液,其特征在于,按照重量份数包括以下有效组份:当归10份、地榆20份、紫草10份、大黄10份、黄连8份、黄柏10份、虎杖5份、乳香8份、刘寄奴10份、白及7份、白芷8份、没药7份、苦楝皮5份、冰片6份、龙血竭10份。
4.制备上述1~3任一项所述的伤口快速愈合中药提取液的方法,其特征在于,包括以下步骤:
a、将准备好的中药组份在沸水中快速浸泡过滤下,然后迅速捞出,沥干;
b、将沥干后的中药切段成碎末状,然后放入锅内干锅翻炒;
c、将翻炒过后的中药放入锅中,加水,慢火熬制1小时;
d、待锅内药水冷却后,将中药以及药水放入发酵罐内,添加菌种,进行发酵;
e、待发酵完成后,取出发酵好的中药及药水,过滤,得到过滤液;
f、将过滤液进行高温压缩,压缩至相对浓度为1.5~1.7,即得到成品。
5.根据权利要求4所述的伤口快速愈合中药提取液的制备方法,其特征在于,所述c步骤中,加水量为中药总重量的2~3倍。
6.根据权利要求4所述的伤口快速愈合中药提取液的制备方法,其特征在于,所述d步骤中,菌种为酵母菌和双歧杆菌的混合物,所述添加菌种的量为中药总重量的1%~4%。
7.根据权利要求6所述的伤口快速愈合中药提取液的制备方法,其特征在于,所述酵母菌和双歧杆菌的质量比为1:1.5。
8.根据权利要求7所述的伤口快速愈合中药提取液的制备方法,其特征在于,所述双歧杆菌为长双歧杆菌、短双歧杆菌、卵形双歧杆菌、嗜热双歧杆菌中的至少一种有益菌。
9.根据权利要求4所述的伤口快速愈合中药提取液的制备方法,其特征在于,所述d步骤中,控制发酵罐内发酵温度24℃~28℃,发酵时间为28~48小时。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610405399.0A CN105963527A (zh) | 2016-06-07 | 2016-06-07 | 伤口快速愈合中药提取液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610405399.0A CN105963527A (zh) | 2016-06-07 | 2016-06-07 | 伤口快速愈合中药提取液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105963527A true CN105963527A (zh) | 2016-09-28 |
Family
ID=57010906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610405399.0A Pending CN105963527A (zh) | 2016-06-07 | 2016-06-07 | 伤口快速愈合中药提取液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105963527A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108992581A (zh) * | 2018-09-29 | 2018-12-14 | 湖南省善恩祥药业有限公司 | 一种用于治疗皮损的中药膏及其制备方法 |
CN111789915A (zh) * | 2020-08-31 | 2020-10-20 | 吴荣东 | 一种外用中草药粉对糖尿足敷料及其制备方法 |
CN114767786A (zh) * | 2022-05-13 | 2022-07-22 | 中南民族大学 | 一种防治液氮超低温冻伤的外用生肤油及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102895526A (zh) * | 2012-10-31 | 2013-01-30 | 唐和斌 | 一种治疗烧烫伤的外用生肤油及其制备方法和应用 |
CN103565921A (zh) * | 2013-11-04 | 2014-02-12 | 王立发 | 一种治疗褥疮以及伤口快速愈合特效药 |
CN103830506A (zh) * | 2014-01-24 | 2014-06-04 | 河南科技大学第一附属医院 | 一种用于伤口快速愈合的复方药膏及其制备方法 |
CN105267450A (zh) * | 2015-12-02 | 2016-01-27 | 白帅军 | 一种外伤创面修复的中药组合物 |
-
2016
- 2016-06-07 CN CN201610405399.0A patent/CN105963527A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102895526A (zh) * | 2012-10-31 | 2013-01-30 | 唐和斌 | 一种治疗烧烫伤的外用生肤油及其制备方法和应用 |
CN103565921A (zh) * | 2013-11-04 | 2014-02-12 | 王立发 | 一种治疗褥疮以及伤口快速愈合特效药 |
CN103830506A (zh) * | 2014-01-24 | 2014-06-04 | 河南科技大学第一附属医院 | 一种用于伤口快速愈合的复方药膏及其制备方法 |
CN105267450A (zh) * | 2015-12-02 | 2016-01-27 | 白帅军 | 一种外伤创面修复的中药组合物 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108992581A (zh) * | 2018-09-29 | 2018-12-14 | 湖南省善恩祥药业有限公司 | 一种用于治疗皮损的中药膏及其制备方法 |
CN111789915A (zh) * | 2020-08-31 | 2020-10-20 | 吴荣东 | 一种外用中草药粉对糖尿足敷料及其制备方法 |
CN114767786A (zh) * | 2022-05-13 | 2022-07-22 | 中南民族大学 | 一种防治液氮超低温冻伤的外用生肤油及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11571452B2 (en) | Method of treating a skin wound with a liquid-state topical pharmaceutical composition | |
CN102125634A (zh) | 一种治疗褥疮的中药组合物 | |
CN103230493B (zh) | 一种治疗创口不愈的中药组合物 | |
CN105250696A (zh) | 一种促进皮肤伤口愈合的中药凝胶剂及其制备方法 | |
CN105963527A (zh) | 伤口快速愈合中药提取液及其制备方法 | |
CN105362410B (zh) | 一种治疗烧烫伤的中药制剂及制备方法 | |
CN103656092A (zh) | 一种治疗外伤的药膏及其制备方法 | |
CN105168361A (zh) | 一种治疗烧烫伤的植物油复方擦剂及其制备方法 | |
CN101401890B (zh) | 能有效治疗创面感染的外用药 | |
CN101468166A (zh) | 一种治疗手足皲裂的药物组合及其制备方法 | |
CN102727698B (zh) | 一种治疗褥疮的创面护理粉 | |
CN108721442B (zh) | 治疗烧烫伤及尿布皮炎的中药组合物、制剂及其制备方法 | |
CN101036712A (zh) | 烫烧伤软膏 | |
CN113197973A (zh) | 一种药物组合物及其制备方法 | |
CN104800427A (zh) | 一种烧烫伤康复敷剂及其制备方法 | |
CN111991471A (zh) | 一种治疗刀伤、创伤、烧烫伤的外用中药制剂及其制备方法 | |
CN105311473A (zh) | 快速止血的药物 | |
CN103721056A (zh) | 一种治疗烧烫伤的纯中草药油剂 | |
CN103127274A (zh) | 一种四季火烧烫伤药 | |
CN103263496A (zh) | 一种用于治疗烧伤的药物组合物 | |
CN102441061A (zh) | 一种快速治疗烧伤、烫伤的中药组合物及其制备方法 | |
CN102920800A (zh) | 一种外用药物组合物及其应用和制备方法 | |
CN103394009B (zh) | 一种治疗外伤和糠尿病足溃疡的中药及制备方法 | |
CN109045204A (zh) | 一种治疗烧伤和烫伤的中药液及其制备方法 | |
CN108420877A (zh) | 一种治疗跌打损伤与消肿止痛中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160928 |